Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Hospital systems were comparably affected, for example, UPMC out of Pittsburgh posted an even larger loss of about $370 million over the same term, which it attributed to increased medical utilization and pharmacy costs, while Highmark Health - also of Pittsburgh - despite avoiding operational losses, reported a significant decline in operating gains in 2024 relative to 2023, which administrators blame on high prescription drug costs - most notably GLP-1s
Stipanuk, M
Generic semaglutide will launch in March 2026 when Novo Nordisks patent expires
Athletes subject to USADA, UKAD, or other WADA-signatory testing programs should be aware of this status
EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice
US$ 21.95
US$ 22.93
US$ 23.40
US$ 26.82
